Arena Pharmaceutical Inc. (ARNA) News Headlines

▮ More

Date

Headline

11/4/2021 5:22:21 PM Arena Pharma Q3 Loss/share $3.21 Vs. Loss $1.69 Year Ago

11/4/2021 5:19:16 PM Arena Pharmaceutical Inc. Q3 Earnings Summary

8/5/2021 5:00:21 PM Arena Pharma Q2 Loss/share $2.40 Vs. Loss $1.61 Year Ago

8/5/2021 4:41:30 PM EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q2 Earnings Report

8/5/2021 3:00:18 PM Arena Pharmaceutical Q2 21 Earnings Conference Call At 4:30 PM ET

8/5/2021 7:06:55 AM Second Genome, Arena Pharma Collaborate To Identify Gastrointestinal Biomarkers

5/5/2021 4:59:04 PM EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q1 Earnings Report

5/5/2021 3:03:14 PM Arena Pharmaceutical Q1 21 Earnings Conference Call At 4:30 PM ET

2/23/2021 4:13:13 PM EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q4 Earnings Report

1/13/2021 9:04:11 AM Arena Pharmaceutical To Present At J.P. Morgan Healthcare Conference; Webcast At 10:00 AM ET

12/11/2020 9:01:26 AM Arena Pharmaceuticals To Present Data From The Phase 2b ADVISE Trial - Late-Breaker

12/8/2020 8:39:53 AM Arena Pharma Says Achieves Target Enrollment For Etrasimod Phase 3 ELEVATE UC 52 Trial

11/10/2020 2:35:00 AM ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy

11/9/2020 4:35:10 PM Arena Pharma's Atopic Dermatitis Drug Fails To Meet Primary Endpoint, Stock Down 20%

11/9/2020 4:11:48 PM EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q3 Earnings Report

11/9/2020 4:09:16 PM Arena Pharmaceuticals Q3 Loss/share $1.69 Vs. Loss $.46 Year Ago

11/9/2020 4:04:46 PM Arena Says Etrasimod Did Not Meet Ph 2b Primary Endpoint Of EASI Change From Baseline At Week 12

10/28/2020 8:33:50 AM Arena Pharma Announces Launch Of Longboard Pharmaceuticals With $56 Mln Financing

10/20/2020 4:03:49 PM Arena Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/1/2020 8:31:56 AM Arena Completes Full Enrollment Of Phase 2b CAPTIVATE Trial Evaluating Olorinab